BGB-B455
- Generic Name
- BGB-B455
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
- First Posted Date
- 2025-01-31
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- BeiGene
- Target Recruit Count
- 80
- Registration Number
- NCT06803680
- Locations
- 🇺🇸
Ut Health San Antonio Mays Cancer Center, San Antonio, Texas, United States
🇺🇸Next Oncology, San Antonio, Texas, United States
🇺🇸Adventhealth, Celebration, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath